Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Note Payable (Tables)

12 Months Ended

Nov. 30, 2022

As of November 30, 2022, and November 30, 2021, the note payable obligation was as follows:


	November 30, 2022			November 30, 2021
Note payable - TCB	$	—		$	1,908,433
Note payable - Susser		8,921,437
Unamortized debt issuance costs - TCB		—			(10,368	)
Unamortized debt issuance costs - Susser		(191,035	)		—
Net note payable	$	8,730,402		$	1,898,065
Current portion of note payable	$	150,527		$	1,898,065
Long-term note payable, net of debt issuance costs		8,579,875			—
Total	$	8,730,402		$	1,898,065

Interest expense on the note payable for the years ended November 30, 2022 and November 30, 2021 was as follows:


	November 30, 2022		November 30, 2021
Interest expense on notes payable - TCB	$	18,485	$	118,117
Interest expense on notes payable - Susser		286,242		—
Debt issuance costs - TCB		10,367		56,851
Debt issuance costs - Susser		5,467		—
Total interest expense	$	320,561	$	174,968